At the 44th Annual J.P. Morgan Healthcare Conference, CEO Matthew Hawkins underscored Waystar’s position as an industry leader in the healthcare revenue cycle. He highlighted the company’s cloud-native platform, which delivers hundreds of feature improvements each quarter, and detailed an ambitious product roadmap that increasingly incorporates artificial intelligence. Hawkins noted that Waystar is transitioning from AI hype to tangible client value, with ongoing development of agentic intelligence solutions designed to automate routine workflows and reduce administrative burden across revenue-cycle operations.

On January 12, 2026, Waystar unveiled agentic intelligence capabilities built on its AltitudeAI framework, which has already prevented $15.5 billion in denials within its first year of deployment. This next-generation AI leverages proprietary data drawn from over 7.5 billion annual transactions and one in three U.S. hospital discharges to execute defined tasks, learn from outcomes, and act within client workflows with minimal human intervention. Early results show a 40% reduction in manual correction workload for clinical documentation integrity, as the agentic AI automatically analyzes full medical records, prioritizes 30,000 data points, and pre-populates correction requests with supporting context to ensure accurate reimbursement.

Waystar serves more than 30,000 clients and over 1 million distinct providers, including 16 of the 20 institutions on the U.S. News Best Hospitals list. Its enterprise-grade platform processes over 7.5 billion healthcare payment transactions annually—representing roughly 60% of U.S. patients and $2.4 trillion in gross claims. Following rapid uptake of AltitudeAI’s generative capabilities for denial prevention and recovery, clients have achieved 95% time savings on denial workflows and double-digit improvements in overturn rates, reinforcing the company’s mission to simplify healthcare payments and optimize provider financial performance.